We are live on ! Find out more
CAPR icon

Capricor Therapeutics
CAPR

18 hedge funds and large institutions have $598K invested in Capricor Therapeutics in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

114% more capital invested

Capital invested by funds: $279K → $598K (+$319K)

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

6% more funds holding

Funds holding: 17 → 18 (+1)

1.02% more ownership

Funds ownership: 4.59% → 5.61% (+1%)

Holders
18
Holders Change
+1
Holders Change %
+5.88%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$375K
2
Jane Street
Jane Street
New York
+$33.7K
3
Renaissance Technologies
Renaissance Technologies
New York
+$27.7K
4
Citadel Advisors
Citadel Advisors
Florida
+$17.4K
5
Victory Capital Management
Victory Capital Management
Texas
+$1.91K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
-$52K
2
UBS Group
UBS Group
Switzerland
-$5.55K
3
Deutsche Bank
Deutsche Bank
Germany
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$322K +$375K +268,630 New
Renaissance Technologies
2
Renaissance Technologies
New York
$124K +$27.7K +19,830 +24%
Vanguard Group
3
Vanguard Group
Pennsylvania
$35K – – –
Jane Street
4
Jane Street
New York
$29K +$33.7K +24,150 New
Citadel Advisors
5
Citadel Advisors
Florida
$28K +$17.4K +12,479 +109%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$15K – – –
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$13K – – –
CBA
8
Coastal Bridge Advisors
Connecticut
$13K – – –
US Bancorp
9
US Bancorp
Minnesota
$9K – – –
UBS Group
10
UBS Group
Switzerland
$2K -$5.55K -3,974 -73%
Morgan Stanley
11
Morgan Stanley
New York
$2K – – –
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
$2K +$1.41K +1,013 +159%
Victory Capital Management
13
Victory Capital Management
Texas
$2K +$1.91K +1,370 New
BlackRock
14
BlackRock
New York
$1K – – –
HIIFS
15
Harel Insurance Investments & Financial Services
Israel
$1K – – –
Two Sigma Investments
16
Two Sigma Investments
New York
– -$52K -40,680 Closed
Deutsche Bank
17
Deutsche Bank
Germany
– -$2K -2,170 Closed
Wells Fargo
18
Wells Fargo
California
– +$32 +23 New

CAPR Hedge Fund Activity: Q1 2020 in Review

18 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Capricor Therapeutics (CAPR) for Q1 2020, worth a combined $598K — up 114% from $279K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new CAPR positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $375K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $52K sold.

  • 18 institutional investors held Capricor Therapeutics (CAPR) as of Q1 2020, up from 17 in Q4 2019.
  • Funds reported $598K of Capricor Therapeutics stock for Q1 2020, up 114% quarter-over-quarter.
  • 4 funds opened new Capricor Therapeutics positions in Q1 2020 and 2 closed out, a net change of +2 holders.
  • The largest Capricor Therapeutics buyer in Q1 2020 was Armistice Capital, an estimated $375K added.
  • The largest Capricor Therapeutics seller in Q1 2020 was Two Sigma Investments, an estimated $52K sold.

Based on aggregated 13F filings for Q1 2020.